Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand?

Barbhaiya M, Erkan D.

Curr Rheumatol Rep. 2011 Feb;13(1):59-69. doi: 10.1007/s11926-010-0149-3. Review.

PMID:
21104348
2.

Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.

Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM.

Arthritis Rheum. 2009 Jan 15;61(1):29-36. doi: 10.1002/art.24232.

3.

Antiphospholipid syndrome.

Erkan D, Lockshin MD.

Curr Opin Rheumatol. 2006 May;18(3):242-8. Review.

PMID:
16582686
4.

Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals.

Erkan D, Harrison MJ, Levy R, Peterson M, Petri M, Sammaritano L, Unalp-Arida A, Vilela V, Yazici Y, Lockshin MD.

Arthritis Rheum. 2007 Jul;56(7):2382-91.

5.

A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome.

Erkan D, Yazici Y, Peterson MG, Sammaritano L, Lockshin MD.

Rheumatology (Oxford). 2002 Aug;41(8):924-9.

6.

New approaches for managing antiphospholipid syndrome.

Erkan D, Lockshin MD.

Nat Clin Pract Rheumatol. 2009 Mar;5(3):160-70. doi: 10.1038/ncprheum1017. Review.

PMID:
19252521
7.

Primary prevention in antiphospholipid antibody carriers.

Bertero MT.

Lupus. 2012 Jun;21(7):751-4. doi: 10.1177/0961203312445229.

PMID:
22635222
8.

A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies.

Ruiz-Irastorza G, Hunt BJ, Khamashta MA.

Arthritis Rheum. 2007 Dec 15;57(8):1487-95. Review.

9.

How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive.

Giles I, Rahman A.

Best Pract Res Clin Rheumatol. 2009 Aug;23(4):525-37. doi: 10.1016/j.berh.2009.01.009.

PMID:
19591782
10.

Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up.

Tarr T, Lakos G, Bhattoa HP, Soltesz P, Shoenfeld Y, Szegedi G, Kiss E.

Clin Rev Allergy Immunol. 2007 Apr;32(2):131-7.

PMID:
17916982
11.

Thrombosis in systemic lupus erythematosus: risk and protection.

Burgos PI, Alarcón GS.

Expert Rev Cardiovasc Ther. 2009 Dec;7(12):1541-9. doi: 10.1586/erc.09.137. Review.

PMID:
19954316
12.

Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus.

Martínez-Berriotxoa A, Ruiz-Irastorza G, Egurbide MV, Rueda M, Aguirre C.

Lupus. 2004;13(12):927-33.

PMID:
15645748
13.

Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.

Tarr T, Lakos G, Bhattoa HP, Shoenfeld Y, Szegedi G, Kiss E.

Lupus. 2007;16(1):39-45.

PMID:
17283584
14.
15.

Management of antiphospholipid syndrome.

Tuthill JI, Khamashta MA.

J Autoimmun. 2009 Sep;33(2):92-8. doi: 10.1016/j.jaut.2009.05.002. Epub 2009 Jun 25. Review.

PMID:
19559568
16.

The management of thrombosis in the antiphospholipid-antibody syndrome.

Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR.

N Engl J Med. 1995 Apr 13;332(15):993-7.

17.

Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy.

Ruiz-Irastorza G, Khamashta MA.

Ann N Y Acad Sci. 2005 Jun;1051:606-12. Review.

PMID:
16127001
18.

Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS).

Cuadrado MJ, Bertolaccini ML, Seed PT, Tektonidou MG, Aguirre A, Mico L, Gordon C, Ruiz-Irastorza G, Egurbide MV, Gil A, Espinosa G, Houssiau F, Rahman A, Martin H, McHugh N, Galindo M, Akil M, Amigo MC, Murru V, Khamashta MA.

Rheumatology (Oxford). 2014 Feb;53(2):275-84. doi: 10.1093/rheumatology/ket313. Epub 2013 Oct 4.

19.

Current management of antiphospholipid syndrome-related thrombosis.

Puente D, Pombo G, Forastiero R.

Expert Rev Cardiovasc Ther. 2009 Dec;7(12):1551-8. doi: 10.1586/erc.09.112. Review.

PMID:
19954317
20.

Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies.

Arnaud L, Mathian A, Devilliers H, Ruffatti A, Tektonidou M, Forastiero R, Pengo V, Lambert M, Lefevre G, Martinez-Zamora MA, Balasch J, Wahl D, Amoura Z.

Autoimmun Rev. 2015 Mar;14(3):192-200. doi: 10.1016/j.autrev.2014.10.019. Epub 2014 Oct 22. Review.

PMID:
25461472
Items per page

Supplemental Content

Write to the Help Desk